• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Environ Res Public Health . IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection

tetano

Editor, Senior Moderator
Int J Environ Res Public Health


. 2021 Feb 1;18(3):1318.
doi: 10.3390/ijerph18031318.
IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection


Antonella De Donno[SUP] 1 [/SUP], Giambattista Lobreglio[SUP] 2 [/SUP], Alessandra Panico[SUP] 1 [/SUP], Tiziana Grassi[SUP] 1 [/SUP], Francesco Bagordo[SUP] 1 [/SUP], Maria Pia Bozzetti[SUP] 1 [/SUP], Serafina Massari[SUP] 1 [/SUP], Luisa Siculella[SUP] 1 [/SUP], Fabrizio Damiano[SUP] 1 [/SUP], Francesco Guerra[SUP] 2 [/SUP], Marilena Greco[SUP] 2 [/SUP], Michele Chicone[SUP] 2 [/SUP], Roberta Lazzari[SUP] 2 [/SUP], Pietro Alifano[SUP] 1 [/SUP]



Affiliations

Abstract

The emergence of coronavirus disease 2019 (COVID-19) is globally a major healthcare threat. There is little information regarding the mechanisms and roles of the humoral response in SARS-CoV-2 infection. The aim of this study was to analyze the antibody levels (IgM and IgG) by chemiluminescence immunoassay in 54 subjects positive to SARS-CoV-2 swab test in relation to their clinical status (whether asymptomatic, pauci-symptomatic or with mild, sever or critical symptoms), the time from the symptom onset, sex, age, and comorbidities. Overall, the presence of comorbidities and the age of subjects were associated with their clinical status. The IgG concentrations were significantly higher in patients who developed critical and severe symptoms and seemed to be independent from age, sex and comorbidities. IgG titers peaked around day 60, and then began gradually to drop, decreasing by approximately 50% on the 180th day, while the IgM titers progressively decreased as early as the tenth day, but they could be detected even at later time points. Despite the small number of individuals, some peculiar characteristics of the humoral response in COVID-19 emerged. We observed a high inter-individual variability, an ephemeral IgG half-life in several patients, and a persistence of IgM in others.

Keywords: COVID-19; SARS-CoV-2; antibodies; humoral immunity.
 
Back
Top Bottom